NRX Pharmaceuticals, Inc. (NRXP) Shareholders’ equity 2023–2025
NRX Pharmaceuticals, Inc. (NRXP) shareholders’ equity at each fiscal year-end, per SEC filings.
-$15.9MFY2025 · since FY2023: -$11.7M → -$15.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$15.9M | +31.4% |
| FY2024 | -$23.2M | -97.9% |
| FY2023 | -$11.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice